545
Participants
Start Date
May 6, 2015
Primary Completion Date
January 23, 2019
Study Completion Date
December 31, 2025
Ramucirumab
Administered IV.
Placebo
Administered IV.
Erlotinib
Administered orally.
Gefitinib
Administered orally.
Osimertinib
Administered orally.
National Cheng-Kung University Hospital, Tainan City
Baskent University Dr. Turgut Noyan Research and Training Center, Adana
National Taiwan University Hospital, Taipei
Azienda Sanitaria Ospedaliera S Luigi Gonzaga, Orbassano
Seoul National University Bundang Hospital, Seongnam
MacKay Memorial Hospital, Taipei
Taipei Veterans General Hospital, Taipei
Queens Medical Associates, Fresh Meadows
Sotiria Thoracic Diseases Hospital of Athens, Athens
Helios Klinikum Emil von Behring Berlin-Zehlendorf, Berlin
AHN Allegheny General Hospital, Pittsburgh
The Catholic University Of Korea St. Vincent's Hospital, Suwon
Ajou University Hospital, Suwon
Ospedale San Raffaele, Milan
Trakya University, Edirne
LungenClinic Grosshansdorf, Großhansdorf
Hospital Universitario 12 de Octubre, Madrid
Levine Cancer Institute, Charlotte
Hospital Universitario Quironsalud Madrid, Pozuelo de Alarcón
Chungbuk National University Hospital, Cheongju-si
Clinica Universitaria De Navarra, Pamplona
Cro-Irccs, Aviano
Hôpital Arnaud de Villeneuve - CHU Montpellier, Montpellier
Ege Universitesi Hastanesi, Bornova
Istituto Oncologico Veneto IRCCS, Padua
Chu Grenoble Alpes, La Tronche
IRCCS - AOU di Bologna, Bologna
China Medical University Hospital, Taichung
Taichung Veterans General Hospital, Taichung
Hospital Universitario Virgen del Rocio, Seville
Hospital Universitario Virgen de Valme, Seville
Ulsan University Hospital, Ulsan
İnönü Üniversitesi Turgut Özal Tıp Merkezi Eğitim ve Araştırma Hastanesi, Malatya
Hospital Universitari i Politecnic La Fe, Valencia
Klinikum Köln-Merheim, Cologne
Gyeongsang National University Hospital, Jinju
Hopital Claude Huriez - CHU de Lille, Lille
Cancer Center of Kansas, Wichita
Thoraxklinik Heidelberg gGmbH, Heidelberg
Instituto Tumori Giovanni Paolo II, Bari
Robert-Bosch-Krankenhaus, Gerlingen
Hôpital Européen Georges Pompidou, Paris
St. Charles Health System, Denver
E-DA Hospital, Kaohsiung City
Chang Gung Memorial Hospital at Kaohsiung, Kaohsiung Niao Sung Dist
Centre Hospitalier Universitaire de Poitiers, Poitiers
UCLA Hematology/Oncology - Santa Monica, Los Angeles
The Gastroenterology Group, P.C., Honolulu
S.C. MedisProf SRL, Cluj-Napoca
Queen Elizabeth Hospital, Yau Ma Tei
National Hospital Organization Kinki-Chuo Chest Medical Center, Sakai
Sendai Kousei Hospital, Sendai
Cross Cancer Institute, Edmonton
Klinikum Chemnitz GmbH, Chemnitz
Städtisches Krankenhaus Martha-Maria Halle-Dölau gGmbH, Halle
Queen Mary Hospital, Hong Kong
Aichi Cancer Center Hospital, Nagoya
National Cancer Center Hospital East, Kashiwa
Ehime University Hospital, Tōon
Kurume University Hospital, Kurume
National Hospital Organization Asahikawa Medical Center, Asahikawa
Hyogo Cancer Center, Akashi
Hyogo Prefectual Amagasaki General Medical Center, Amagashiki
Himeji Medical Center, Himeji
Foundation for Biomedical Research and innovation, Kobe
Kobe City Medical Center General Hospital, Kobe
Kanazawa University Hospital, Kanazawa
Kanagawa Cardiovascular and Respiratory Center, Yokohama
Kanagawa Cancer Center, Yokohama
Niigata Cancer Center Hospital, Niigata
Osaka Habikino Medical Center, Habikino
Kansai Medical University Hospital, Hirakata
Kishiwada City Hospital, Kishiwada
Kindai University Hospital- Osakasayama Campus, Ōsaka-sayama
Saitama Prefectural Cancer Center, Ina-machi
Shizuoka Cancer Center, Nakatogari
Tokyo Met Cancer & Infectious Diseases Center Komagome Hp, Bunkyo-ku
National Cancer Center Hospital, Chuo-Ku
Japanese Foundation for Cancer Research, Koto
National Hospital Organization Yamaguchi Ube Medical Center, Ube
Chiba University Hospital, Chiba
National Hospital Organization Kyushu Medical Center, Fukuoka
National Hospital Organization Kyushu Cancer Center, Fukuoka
Kyushu University Hospital, Fukuoka
Kyoto University Hospital, Kyoto
Nagasaki University Hospital, Nagasaki
Niigata University Medical & Dental Hospital, Niigata
Okayama University Hospital, Okayama
Osaka City General Hospital, Osaka
Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka
Osaka City University Hospital, Osaka
St. Lukes International Hospital, Tokyo
Juntendo University Hospital, Tokyo
Nippon Medical School Hospital, Tokyo
Wakayama MedicaL University Hospital, Wakayama
Institutul Oncologic, Bucharest
Asan Medical Center, Seoul
Samsung Medical Center, Seoul
The Catholic Univ. of Korea Seoul St. Mary's Hospital, Seoul
Korea University Guro Hospital, Seoul
Hospital Universitari Vall d'Hebron, Barcelona
Instituto Catalan de Oncologia - Hospital Duran i Reynals, Hospitalet
Hospital Son Llatzer, Palma
Royal Marsden Hospital (Chelsea), London
Charing Cross Hospital, Chelsea
City Hospital, Nottingham University Hospitals, Nottingham
Eli Lilly and Company
INDUSTRY